Nano Pharmaceuticals
Market Cap
₹203 ₹203 Cr.
P/E
0.00
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.52
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
22.91 %
Institutions
Institutions
-
Market cap
Market cap
203 Cr
No. of Shareholders
No. of Shareholders
8,756
OPM (%)
OPM (%)
-0.40 %
PE
PE
-
Prom Holding
Prom Holding
50.92 %
ROCE (%)
ROCE (%)
-5.64
ROE (%)
ROE (%)
-
Sales
Sales
190 Cr
  • Natural Capsules
  • Oxygenta Pharma
  • Accretion Nutraveda
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      138
      52W Range
      High
      296
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      5 Yes

      Positive for this company

      2 Neutral

      Neutral for this company

      8 No

      Negative for this company

      1 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Location Wise Break-Up

      Operating Profit Break-Up

      Asset Break-Up

      Peer Comparison

      Corporate Actions

      Consolidated
      DATE
      DETAILS
      Show More
      Show Less
      Show More
      Show Less

      FAQs on Natural Capsules Ltd. Business

      Natural Capsules Limited is a public limited company with modern manufacturing plants in Bangalore and Pondicherry. It specializes in producing hard gelatin and cellulose capsule shells, meeting cGMP and cGLP standards, and providing turnkey solutions.

      Natural Capsules major competitors are Brooks Laboratories, Bio Medica Labs., Oxygenta Pharma, Chemkart India, Coral Laboratories, Sanjivani Paranteral, Accretion Nutraveda.
      Market Cap of Natural Capsules is ₹209 Crs.
      While the median market cap of its peers are ₹204 Crs.

      Natural Capsules seems to be less financially stable compared to its competitors.
      Altman Z score of Natural Capsules is 1.62 and is ranked 7 out of its 8 competitors.

      Company Filing

      Discussions & Analysis

      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material